Liquid Chromatographic Analysis of Arabinosylcytosin and 1-β-D-Arabinofuranosyluracil in Treatment with Cyclophosphamide and Pirarubicin

A reversed-phase liquid chromatographic (RPLC) method has been developed for determination of arabinosylcytosin (Ara-C) and its metabolite 1-β-D-arabinofuranosyluracil (Ara-U) on a 250 mm × 4.6 mm i.d., 5 µm particle, Diamonsil C₁₈ column. The mobile phase was a mixture of 5% methanol and 95% 10 mmol L^?1 phosphate buffer adjusted to pH 5.5. The flow-rate was 1.0 mL min^?1 and the injection volume 20 μL. Eluting compounds were detected at 270 nm by use of an ultraviolet detector. Under these LC conditions cyclophosphamide (CTX) and pirarubicin (THP), two other medicines given with Ara-C in clinical treatment, do not interfere with measurement of Ara-C and Ara-U. Individual calibration plots of peak area against concentration generated from analysis of standard solutions were used to calculate the concentrations of Ara-C and Ara-U in sample solutions. The calibration plot was linear in the range 2.5–100 µg mL^?1, the average recovery of Ara-C and Ara-U was more than 98% (RSD < 2.5%), and between-day and within-day precision, expressed as relative standard deviation (RSD), were below 4.0%. LOQ for both Ara-C and Ara-U was 2 µg mL^?1. The method is rapid, simple, accurate and reproducible, and especially useful for application to patient samples.